Z

Zymeworks Inc
F:0OX

Watchlist Manager
Zymeworks Inc
F:0OX
Watchlist
Price: 26.85 EUR 3.87% Market Closed
Market Cap: 1.2B EUR

Relative Value

0OX price has not been updated for more than 2 years. This may indicate that the stock has been delisted.

There is not enough data to reliably calculate the relative value of 0OX.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

0OX Relative Value
Base Case
Not Available
Z
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
17.6
Median 5Y
18.8
Industry
8.2
Forward
11.5
vs History
vs Industry
Median 3Y
-11.2
Median 5Y
-7.5
Industry
24.2
Forward
-22.1
vs History
vs Industry
Median 3Y
-11.3
Median 5Y
-9.6
Industry
23
vs History
vs Industry
Median 3Y
-10.9
Median 5Y
-9.2
Industry
25.5
vs History
vs Industry
Median 3Y
2.9
Median 5Y
3.1
Industry
3.3
vs History
vs Industry
Median 3Y
12.7
Median 5Y
13.9
Industry
8.6
Forward
8.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.5
vs History
vs Industry
Median 3Y
-7.5
Median 5Y
-5.5
Industry
6.1
Forward
-9.4
vs History
vs Industry
Median 3Y
-7
Median 5Y
-5.4
Industry
6.6
Forward
-13.7
vs History
vs Industry
Median 3Y
-8.1
Median 5Y
-7.1
Industry
8.8
vs History
vs Industry
Median 3Y
-7.8
Median 5Y
-6.8
Industry
6.8
vs History
vs Industry
Median 3Y
4.8
Median 5Y
5.4
Industry
5.7

Multiples Across Competitors

0OX Competitors Multiples
Zymeworks Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Zymeworks Inc
F:0OX
1.2B EUR 19 -12.1 -8.3 -7.7
IL
Can Fite Biopharma Ltd
TASE:CANF
707T ILS 256 727 549 -17 630 396.1 -17 300 817.5 -17 262 306.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 036 074.3 -161 768.4 -196 438.5 -194 196.9
US
Abbvie Inc
NYSE:ABBV
389B USD 6.5 165.7 16.1 22.8
US
Amgen Inc
NASDAQ:AMGN
175.4B USD 4.9 25 18.1 18.1
US
Gilead Sciences Inc
NASDAQ:GILD
150.4B USD 5.2 18.5 12.4 12.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.8B USD 10.1 32.1 23.5 24.6
US
Epizyme Inc
F:EPE
94.1B EUR 2 069.8 -528.2 -575.1 -559.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
83.9B USD 5.9 18.3 17.5 19.9
AU
CSL Ltd
ASX:CSL
84.4B AUD 3.6 18.8 12.7 15.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.5B USD 16.4 1 204.9 162.5 197
P/S Multiple
Revenue Growth P/S to Growth
CA
Z
Zymeworks Inc
F:0OX
Average P/S: 26 433 251.3
19
26%
0.7
IL
C
Can Fite Biopharma Ltd
TASE:CANF
256 727 549
140%
1 833 768.2
FR
Pharnext SCA
OTC:PNEXF
34 036 074.3
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.5
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.9
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.2
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.1
10%
1
US
E
Epizyme Inc
F:EPE
2 069.8
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.9
6%
1
AU
CSL Ltd
ASX:CSL
3.6
5%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
16.4
46%
0.4
P/E Multiple
Earnings Growth PEG
CA
Z
Zymeworks Inc
F:0OX
Average P/E: 211.9
Negative Multiple: -12.1
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
Negative Multiple: -17 630 396.1 N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 768.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
165.7
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.5
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
32.1
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -528.2 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.3
10%
1.8
AU
CSL Ltd
ASX:CSL
18.8
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 204.9
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Z
Zymeworks Inc
F:0OX
Average EV/EBITDA: 37.6
Negative Multiple: -8.3
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
Negative Multiple: -17 300 817.5 N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 438.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.1
14%
1.1
US
Amgen Inc
NASDAQ:AMGN
18.1
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -575.1 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.5
11%
1.6
AU
CSL Ltd
ASX:CSL
12.7
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
162.5
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Z
Zymeworks Inc
F:0OX
Average EV/EBIT: 44.4
Negative Multiple: -7.7
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
Negative Multiple: -17 262 306.3 N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 196.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.8
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.1
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.6
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -559.8 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.9
13%
1.5
AU
CSL Ltd
ASX:CSL
15.8
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
197
N/A N/A